Macrocyclic peptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9090671
APP PUB NO 20090312300A1
SERIAL NO

12479633

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are cyclosporine derivatives in which the 3-Sarcosine carbon and 5-Valine nitrogen are each substituted by a non-hydrogen substituent, and their use as pharmaceuticals, in particular for the treatment of hepatitis C virus.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CYPRALIS LIMITEDBABRAHAM HALL BABRAHAM CAMBRIDGE CB22 3AT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Li, Keqiang Cary, US 55 85
Mamai, Ahmed Raleigh, US 21 54
Peel, Michael Robert Research Triangle Park, US 21 222

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 28, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00